At a glance
- Originator Medicure
- Class Anti-ischaemics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Myocardial infarction
Most Recent Events
- 23 Jul 2003 Discontinued - Preclinical for Myocardial infarction in Canada (unspecified route)
- 25 Mar 2003 This compound is still in active development
- 22 Apr 2002 Preclinical trials in Myocardial infarction in Canada (unspecified route)